Fabrication, Physicochemical Characterization, and in Silico Evaluation of Bilayer Nanofibers as a Potential Sustained Crocin Delivery Dressing

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Nazanin Goshtasbi, Fatemeh Mehryab, Seyed Alireza Mortazavi, Raziyeh Ghorbani, Azadeh Haeri
{"title":"Fabrication, Physicochemical Characterization, and in Silico Evaluation of Bilayer Nanofibers as a Potential Sustained Crocin Delivery Dressing","authors":"Nazanin Goshtasbi,&nbsp;Fatemeh Mehryab,&nbsp;Seyed Alireza Mortazavi,&nbsp;Raziyeh Ghorbani,&nbsp;Azadeh Haeri","doi":"10.1007/s12247-024-09838-6","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>This research aimed to produce zein-based bilayer nanofibers to sustain the release of crocin. Zein and gelatin were blended to form the drug-eluting layer, while polycaprolactone (PCL) was used to fabricate the backing layer.</p><h3>Methods</h3><p>Bilayer nanofibers were fabricated through sequential electrospinning. For fabricating the drug-eluting layer, zein solutions at the concentrations of 30% and 40% w/v were prepared and blended with gelatin solution (20% w/v) at four zein/gelatin solution mass ratios. After finding the optimized solution, PCL (12% w/v) was electrospun on the drug-eluting layer. The prepared nanofibers were characterized regarding morphology, FTIR, XRD, water contact angle, swelling, in vitro release, and mechanical properties. Molecular docking studies were also used to demonstrate interactions in crocin-zein and crocin-gelatin complexes.</p><h3>Results</h3><p>SEM micrographs showed that the ideal nanofibers consisted of zein 40% w/v and gelatin 20% w/v with a zein/gelatin solution mass ratio of 80:20. These nanofibers had an average diameter of ~ 500 nm and showed a good yield in the production process. Solid state characterizations (FTIR and XRD) demonstrated compatibility between crocin and the polymers. The bilayer nanofibers exhibited sustained release of crocin (up to 56.6% in 5 days) by preventing the shrinkage of the zein/gelatin nanofibers. Additionally, the bilayer nanofibers exhibited improved mechanical properties. Computational characterization showed favorable binding energies of -5.9 kcal/mol for the gelatin-crocin complex and -5.6 kcal/mol for the zein-crocin complex.</p><h3>Conclusion</h3><p>Based on the findings, it appears that the zein-based bilayer nanofibers could be an effective delivery system for crocin, potentially providing a sustained release for localized applications.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"19 3","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-024-09838-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

This research aimed to produce zein-based bilayer nanofibers to sustain the release of crocin. Zein and gelatin were blended to form the drug-eluting layer, while polycaprolactone (PCL) was used to fabricate the backing layer.

Methods

Bilayer nanofibers were fabricated through sequential electrospinning. For fabricating the drug-eluting layer, zein solutions at the concentrations of 30% and 40% w/v were prepared and blended with gelatin solution (20% w/v) at four zein/gelatin solution mass ratios. After finding the optimized solution, PCL (12% w/v) was electrospun on the drug-eluting layer. The prepared nanofibers were characterized regarding morphology, FTIR, XRD, water contact angle, swelling, in vitro release, and mechanical properties. Molecular docking studies were also used to demonstrate interactions in crocin-zein and crocin-gelatin complexes.

Results

SEM micrographs showed that the ideal nanofibers consisted of zein 40% w/v and gelatin 20% w/v with a zein/gelatin solution mass ratio of 80:20. These nanofibers had an average diameter of ~ 500 nm and showed a good yield in the production process. Solid state characterizations (FTIR and XRD) demonstrated compatibility between crocin and the polymers. The bilayer nanofibers exhibited sustained release of crocin (up to 56.6% in 5 days) by preventing the shrinkage of the zein/gelatin nanofibers. Additionally, the bilayer nanofibers exhibited improved mechanical properties. Computational characterization showed favorable binding energies of -5.9 kcal/mol for the gelatin-crocin complex and -5.6 kcal/mol for the zein-crocin complex.

Conclusion

Based on the findings, it appears that the zein-based bilayer nanofibers could be an effective delivery system for crocin, potentially providing a sustained release for localized applications.

Graphical Abstract

Abstract Image

双层纳米纤维的制备、理化表征和硅学评估--作为一种潜在的克罗恩持续给药敷料
目的 本研究旨在制备基于玉米蛋白的双层纳米纤维,以维持羊角霉素的释放。方法通过顺序电纺制造双层纳米纤维。为了制造药物洗脱层,制备了浓度为 30% 和 40% w/v 的玉米蛋白溶液,并以四种玉米蛋白/明胶溶液的质量比将其与明胶溶液(20% w/v)混合。找到最佳溶液后,在药物洗脱层上电纺 PCL(12% w/v)。所制备的纳米纤维在形态、傅立叶变换红外光谱、X射线衍射、水接触角、溶胀、体外释放和机械性能等方面均有特征。结果SEM 显微照片显示,理想的纳米纤维由 40% w/v 的玉米蛋白和 20% w/v 的明胶组成,玉米蛋白/明胶溶液的质量比为 80:20。这些纳米纤维的平均直径约为 500 nm,在生产过程中显示出良好的产量。固态表征(傅立叶变换红外光谱和 X 射线衍射)表明,牛黄素与聚合物之间具有相容性。通过防止玉米蛋白/明胶纳米纤维的收缩,双层纳米纤维表现出了持续释放黄曲霉素的能力(5 天内释放量可达 56.6%)。此外,双层纳米纤维还具有更好的机械性能。计算表征结果表明,明胶-藏红霉素复合物的结合能为-5.9 kcal/mol,玉米蛋白-藏红霉素复合物的结合能为-5.6 kcal/mol。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation PHARMACOLOGY & PHARMACY-
CiteScore
3.70
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science, Product design, Process design, optimization, automation and control, Facilities; Information management, Regulatory policy and strategy, Supply chain developments , Education and professional development, Journal of Pharmaceutical Innovation publishes four issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信